查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1631614

藥品包裝器材：市場佔有率分析、產業趨勢/統計、成長預測（2025-2030）

Pharma Packaging Machinery - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計藥品包裝器材市場在預測期間內的複合年成長率為7.5%。

藥品包裝機械-市場-IMG1

主要亮點

  • 然而，隨著 COVID-19 疫苗的供應，全球對藥品包裝的需求預計將在未來兩到三年內增加。各個供應商正在擴大產能，以滿足激增的需求。預計將增加全球製藥業對包裝器材的需求。
  • 藥品包裝是採用相容材料製成的藥品運送和儲存的包裝產品。根據藥物的性質，選擇各種材料類型和產品類型的包裝產品，以提供保護、識別並確保封裝藥物的完整性。
  • 由於多種因素，包括不斷增加的全球監管規範以及對人口健康管理和發明的重視，世界各地的製藥業都取得了顯著發展。此外，對非處方藥不斷成長的需求和更知情的客戶群也推動了市場的成長。
  • 藥品包裝市場與藥品市場有著直接的相關性。因為新藥的需求不斷增加，增加了對包裝的需求，從而影響了所研究市場的成長。

藥品包裝器材市場趨勢

製藥業安全標準和法規的存在預計將推動市場發展

  • 製藥業受到嚴格監管，強調製造和包裝過程的安全方面和永續性。整個醫療保健產業正在製定可追溯性法律，以打擊假藥和醫療設備。
  • 例如，在美國，食品藥物管理局(FDA) 負責監管藥品的生產。美國食品藥物管理局(FDA) 透過密切監控藥品製造商是否遵守現行良好生產規範 (CGMP) 法規來確保藥品品質。製藥 CGMP 法規對用於製造、加工和包裝藥品的方法、設備和控制設定了最低要求。
  • 同樣，歐盟法規要求所有藥品製造商在向歐盟供應產品時必須遵守歐盟良好生產規範（GMP）。製造商和進口商必須獲得成員國主管機關的許可和註冊。製造商和進口商定期接受歐盟主管機關或其他核准機構的檢查，以檢查是否符合歐盟 GMP。這些法規進一步增加了對維護良好的先進包裝機械的需求，以避免產品召回。

北美佔據主要市場佔有率

  • 由於製藥業的顯著成長，預計北美地區將在製藥業先進包裝機械的需求中佔據主導地位，從而推動該地區的藥品製造業。此外，美國是全球最大的製藥市場，約佔製藥和生技市場研發支出的一半。
  • 已證實，COVID-19疫苗的開發導致相關企業與包裝公司簽訂了生產注射器和管瓶的合約。這些包裝趨勢正在推動包裝設備市場的成長。
  • 此外，隨著疫苗產能的擴大，相關包裝工程公司和OEM對無菌填充線的需求也隨之增加。為了應對這些趨勢，藥品包裝器材製造商正在推出完全整合的系統、具有模組化概念的即插即用解決方案。
  • 此外，根據人類資料科學公司 IQVIA 的數據，全球藥品銷售額預計將從 2019 年的 4,910 億美元增至 2023 年的 1.5 兆美元。美國無論是在消費或開發方面都在醫藥市場上佔據主導地位。根據 STAT 的數據，該國處方藥支出預計將在 2023 年達到 6,000 億美元，高於 2019 年估計的 5,000 億美元。
  • 需要安全處理和安全遏制高活性藥物的適當基礎設施，需要特別適合高活性藥物的分析能力，以及需要適當的計劃管理（包括適當的實施、執行和完成）。隨著該地區藥品製造業的成長，這些趨勢預計將推動該地區包裝器材的需求。

藥品包裝器材產業概況

隨著全球各種機械供應商的出現，全球藥品包裝器材市場的競爭格局適度分散。機械供應商正在參與策略性投資和合作夥伴關係以實現成長。

  • 2021 年 2 月 - Promac 收購了 Serpa Packaging Solutions，這是一家為製藥、醫療設備、營養品、食品、化妝品和個人護理市場提供裝盒和終端包裝系統的製造商。 Serpa 的加入為 ProMach 的產品組合帶來了自動化包裝系統，擴展了其專業的二次包裝器材和生產線整合能力。
  • 2020 年 10 月 - 合約包裝和臨床供應服務提供者Sharp Corporation宣布對設施產能投資 1000 萬美元，以直接支持生技藥品和注射市場的客戶需求。

其他好處：

  • Excel 格式的市場預測 (ME) 表
  • 3 個月分析師支持

目錄

第1章簡介

  • 研究假設和市場定義
  • 調查範圍

第2章調查方法

第3章執行摘要

第4章市場動態

  • 市場概況
  • 產業價值鏈分析
  • 產業吸引力－波特五力分析
    • 新進入者的威脅
    • 買家/消費者的議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間敵對關係的強度
  • 市場促進因素
    • 主要最終用戶市場的高需求
    • 持續的技術開發
    • 製藥業安全標準與法規的影響
  • 市場限制因素
    • 高成本和進口關稅對新客戶來說是一項挑戰
    • 資本密集型製造流程
  • COVID-19對包裝器材產業的影響
  • 技術簡介

第5章市場區隔

  • 按機器類型
    • 初級包裝
      • 無菌灌裝封口設備
      • 灌裝旋蓋設備
      • 泡殼包裝機
      • 其他
    • 二次包裝
      • 裝盒機設備
      • 裝箱包裝設備
      • 包裝設備
      • 托盤包裝機
      • 其他
    • 標籤和序列化
      • 瓶子和安瓿的貼標和序列化設備
      • 紙箱貼標/系列設備
      • 其他
  • 地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東/非洲

第6章 競爭狀況

  • 公司簡介
    • Syntegon Technology GmbH（Robert Bosch GmbH）
    • Romaco Holding GmbH
    • Optima Packaging Group GmbH
    • Marchesini Group SPA
    • Mesoblast Limited
    • IMA Industria Macchine Automatiche SpA
    • MULTIVAC Group
    • Ishida Co. Limited
    • PAC Machinery Group
    • Uhlmann Group
    • Accutek Packaging Equipment Companies, Inc.
    • Vanguard Pharmaceutical Machinery, Inc.
    • MG2 srl

第7章 市場投資機會及未來前景

簡介目錄
Product Code: 72345

The Pharma Packaging Machinery Market is expected to register a CAGR of 7.5% during the forecast period.

Pharma Packaging Machinery - Market - IMG1

Key Highlights

  • However, the global demand for pharmaceutical packaging is expected to increase for the next two to three years for the COVID-19 vaccine supply. Various vendors have been expanding their capacity to meet the surge in demand. This is expected to increase the demand for packaging machinery for the pharmaceutical industry globally.
  • Pharmaceutical packaging is packaging products made using compatible materials for the transfer and storage of drugs. Based on the nature of the drug, packaging products are chosen from a range of material types and product types, provide protection, identification, and ensure the enclosed drug product's integrity.
  • The pharmaceutical industry across the world has evolved considerably, owing to various factors that include the growth in regulatory norms worldwide and focus on population health management and invention. In addition, the growth in the demand for over-the-counter medicines and a more informed customer base is also driving the growth of the market.
  • The pharmaceutical packaging market has a direct correlation with the pharmaceutical market. Any changes in demand for pharmaceutical drugs will impact the packaging market positively, as higher demand for new drugs leads to a greater need for packaging, thereby impacting the growth of the studied market.

Pharmaceutical Packaging Machinery Market Trends

The Presence of Safety Standards & Regulations in the Pharmaceutical Industry Expected to Drive the Market

  • The pharmaceutical industry is highly regulated and is emphasizing the safety and sustainability aspects of manufacturing and packaging processes. Traceability legislations across the healthcare sector have been established to counter counterfeit drugs and medical devices.
  • For instance, the US Food and Drug Administration (FDA) regulates the manufacturing of drugs in the United States. It ensures the quality of drug products by carefully monitoring drug manufacturers' compliance with its Current Good Manufacturing Practice (CGMP) regulations. The CGMP regulations for drugs have set the minimum requirements for the methods, facilities, and controls used in the manufacturing, processing, and packaging of a drug.
  • Similarly, the EU regulations mandate all pharmaceutical manufacturers to comply with the EU Good Manufacturing Practices (GMP), if they want to supply products to the EU. The manufacturers and importers must be authorized and registered by a competent authority from a member state. The manufacturers and importers are regularly inspected by an EU competent authority or other approved authority to check the compliance with the EU GMP. Hence, the presence of such regulations further necessitates the need for well-maintained and advanced packaging machinery to avoid product recalls.

North America Hold a Significant Market Share

  • The North American region is expected to dominate the market in terms of demand for advanced packaging machinery for the pharma industry, owing to the significant growth of the pharmaceutical industry in the region, thereby driving the manufacturing of drugs in the region. Also, the United States is the largest market for drugs worldwide and accounts for about half of the R&D expenditure in the pharmaceutical and biotechnology markets.
  • It is observed that the development of COVID-19 vaccines has led the allied companies to set up agreements with packaging companies for manufacturing syringes and vials. Such packaging trends acts as a major driver of growth in the packaging equipment market.
  • Also, expanding capacities for vaccines has led the allied packaging engineering companies and OEMs witness an increasing demand for aseptic filling lines. in a response to such trends, pharaceutical packaging machinery players are launching fully integrated systems, plug-and-play solutions with modular concepts.
  • Furthermore, according to IQVIA, a human data science company, pharmaceutical sales worldwide are anticipated to reach USD 1.5 trillion in 2023 from USD 491 billion in 2019. The United States dominates the pharmaceutical market, both in consumption and development. According to STAT, prescription drug spending in the nation is considered to add up to USD 600 billion by 2023, up from an estimated USD 500 billion in 2019.
  • The need to have proper infrastructure for the safe handling and safe containment of highly potent drugs, as well as the need for suitable analytical capabilities, particularly for high potency drugs, proper project management (that includes proper induction, running, and completion) highlight the need for R&D. Such trends are expected to boost the demand for packaging machinery in the region, with the growing manufacturing of drugs in the region.

Pharmaceutical Packaging Machinery Industry Overview

The competitive landscape of the global pharmaceutical packaging machinery market is moderately fragmented with the emergence of various machinery providers across the globe. The machinery providers are involved in strategic investments and partnerships for growth.

  • February 2021 - ProMach acquired Serpa Packaging Solutions, a manufacturer of cartoning and end of line packaging systems for the pharmaceutical, medical device, nutraceutical, food, cosmetics, and personal care markets. The addition of Serpa brings automated cartoning systems into ProMach's portfolio and expands its specialized secondary packaging machinery and line integration capabilities.
  • October 2020 - Sharp, a provider of contract packaging and clinical supply services announced an investment of USD 10 million in equipment capabilities to directly support client demand in the biologics and injectables market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Industry Value Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Bargaining Power of Buyers/Consumers
    • 4.3.3 Bargaining Power of Suppliers
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Market Drivers
    • 4.4.1 High Demand in Key End-user Markets
    • 4.4.2 Ongoing Technological Developments
    • 4.4.3 Impact of Safety Standards & Regulations in the Pharmaceutical Industry
  • 4.5 Market Restraints
    • 4.5.1 High Costs and Import Duties Pose a Challenge for New Customers
    • 4.5.2 Capital Intensive Manufacturing Process
  • 4.6 Impact of COVID-19 on the Packaging Machinery Industry
  • 4.7 TECHNOLOGY SNAPSHOT

5 MARKET SEGMENTATION

  • 5.1 By Machinery Type
    • 5.1.1 Primary Packaging
      • 5.1.1.1 Aseptic Filling and Sealing Equipmen
      • 5.1.1.2 Bottle Filling and Capping Equipment
      • 5.1.1.3 Blister Packaging Equipment
      • 5.1.1.4 Others
    • 5.1.2 Secondary Packaging
      • 5.1.2.1 Cartoning Equipment
      • 5.1.2.2 Case Packaging Equipment
      • 5.1.2.3 Wrapping Equipment
      • 5.1.2.4 Tray Packing Equipment
      • 5.1.2.5 Others
    • 5.1.3 Labelling and Serialization
      • 5.1.3.1 Bottle and Ampule Labelling and Serialization Equipment
      • 5.1.3.2 Carton Labelling and Serialization Equipment
      • 5.1.3.3 Others
  • 5.2 Geography
    • 5.2.1 North America
    • 5.2.2 Europe
    • 5.2.3 Asia Pacific
    • 5.2.4 Latin America
    • 5.2.5 Middle East & Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Syntegon Technology GmbH (Robert Bosch GmbH)
    • 6.1.2 Romaco Holding GmbH
    • 6.1.3 Optima Packaging Group GmbH
    • 6.1.4 Marchesini Group SPA
    • 6.1.5 Mesoblast Limited
    • 6.1.6 I.M.A Industria Macchine Automatiche S.p.A
    • 6.1.7 MULTIVAC Group
    • 6.1.8 Ishida Co. Limited
    • 6.1.9 PAC Machinery Group
    • 6.1.10 Uhlmann Group
    • 6.1.11 Accutek Packaging Equipment Companies, Inc.
    • 6.1.12 Vanguard Pharmaceutical Machinery, Inc.
    • 6.1.13 MG2 s.r.l.

7 INVESTMENT OPPORTUNITIES AND FUTURE OUTLOOK OF THE MARKET